News Mar 27, 2024
atai Life Sciences spotlights early depression data for psychedelic ahead of big readout
External link
News Mar 14, 2024
Psychedelic drug ibogaine hailed as healing. U.S. patients ask why it’s illegal.
External link
News Mar 5, 2024
Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction
External link
News Feb 10, 2024
Investors pile into psychedelic drug start-ups tackling mental health
External link
News Dec 13, 2023
Could a little-known psychedelic drug treat opioid addiction? Kentucky wants to find out.
External link
News Nov 17, 2023
Kentucky Summit To Explore Ibogaine Treatment For Opioid Use Disorder
External link
Leadership Apr 7, 2023
Go Higher: atai Life Sciences Is Moving the Dial on Psychedelic Medicine Clinical Trial Outcomes
External link
Leadership Jan 9, 2023
Apps for psychedelic therapy: Necessary innovation or pathway to digital dystopia?
External link
Leadership Dec 5, 2022
A 36-year-old CEO saw how psychedelics treated his best friend’s mental illness. Now his Peter Thiel-funded firm wants to bring the drugs to the masses
External link